Health system first in nation to offer treatment for hereditary amyloidosis
UC San Diego Health is first in the nation to offer a new injectable medication to patients with nerve damage caused by hereditary transthyretin amyloidosis, a rare disease that can be fatal without management. Previously, ...
Aug 18, 2022
0
7